OMIC Singular Genomics Systems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OMIC

Price (delayed)

$0.41

Market cap

$30.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.3

Enterprise value

$88.77M

Highlights
OMIC's revenue is up by 12% since the previous quarter
Singular Genomics Systems's debt has increased by 28% YoY but it has decreased by 2.2% QoQ
OMIC's quick ratio is down by 45% year-on-year and by 23% since the previous quarter
Singular Genomics Systems's equity has decreased by 31% YoY and by 10% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Peers: NWBO

Key stats

What are the main financial stats of OMIC
Market
Shares outstanding
73.93M
Market cap
$30.31M
Enterprise value
$88.77M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.17
Price to sales (P/S)
10.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
30.49
Earnings
Revenue
$2.91M
EBIT
-$93.72M
EBITDA
-$86.5M
Free cash flow
-$74.62M
Per share
EPS
-$1.3
Free cash flow per share
-$1.03
Book value per share
$2.44
Revenue per share
$0.04
TBVPS
$3.65
Balance sheet
Total assets
$265.47M
Total liabilities
$86.46M
Debt
$75.29M
Equity
$179.01M
Working capital
$173.94M
Liquidity
Debt to equity
0.42
Current ratio
10.51
Quick ratio
9.58
Net debt/EBITDA
-0.68
Margins
EBITDA margin
-2,971.4%
Gross margin
-19.2%
Net margin
-3,257.3%
Operating margin
-3,531.5%
Efficiency
Return on assets
-33.3%
Return on equity
-45.3%
Return on invested capital
-34.4%
Return on capital employed
-37.9%
Return on sales
-3,219.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OMIC stock price

How has the Singular Genomics Systems stock price performed over time
Intraday
2.5%
1 week
3.12%
1 month
-20.39%
1 year
-60.95%
YTD
-10.89%
QTD
-20.26%

Financial performance

How have Singular Genomics Systems's revenue and profit performed over time
Revenue
$2.91M
Gross profit
-$558,000
Operating income
-$102.8M
Net income
-$94.82M
Gross margin
-19.2%
Net margin
-3,257.3%
Singular Genomics Systems's net margin has surged by 73% YoY and by 9% QoQ
OMIC's operating margin has surged by 71% year-on-year and by 8% since the previous quarter
OMIC's revenue is up by 12% since the previous quarter
The operating income has declined by 10% year-on-year and by 2.7% since the previous quarter

Growth

What is Singular Genomics Systems's growth rate over time

Valuation

What is Singular Genomics Systems stock price valuation
P/E
N/A
P/B
0.17
P/S
10.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
30.49
Singular Genomics Systems's equity has decreased by 31% YoY and by 10% QoQ
The P/B is 15% below the last 4 quarters average of 0.2
OMIC's price to sales (P/S) is 60% less than its last 4 quarters average of 26.0
OMIC's revenue is up by 12% since the previous quarter

Efficiency

How efficient is Singular Genomics Systems business performance
OMIC's ROS has soared by 73% year-on-year and by 9% since the previous quarter
The ROE has contracted by 44% YoY and by 12% from the previous quarter
The ROA has contracted by 27% YoY and by 8% from the previous quarter
The return on invested capital is up by 3.6% year-on-year

Dividends

What is OMIC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OMIC.

Financial health

How did Singular Genomics Systems financials performed over time
The company's current ratio fell by 45% YoY and by 23% QoQ
OMIC's quick ratio is down by 45% year-on-year and by 23% since the previous quarter
Singular Genomics Systems's debt is 58% lower than its equity
The company's debt to equity has surged by 83% YoY and by 8% QoQ
Singular Genomics Systems's equity has decreased by 31% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.